1887
  1. Home
  2. Eurosurveillance
  3. Volume 28, Issue 31, 03/Aug/2023
  4. Article
Surveillance Open Access
Like 0
Download

Abstract

Background

Invasive infections with beta-haemolytic streptococci of Lancefield groups A (iGAS), B (iGBS) and C/G (iGCGS) are a major cause of morbidity and mortality worldwide.

Aim

We studied incidence trends of invasive beta-haemolytic streptococcal infections in Finland, focusing on iGCGS.

Methods

We conducted a retrospective register-based study. Cases were defined as isolations from blood and/or cerebrospinal fluid and retrieved from the National Infectious Disease Register where all invasive cases are mandatorily notified.

Results

Between 2006 and 2020, the mean annual incidence was 4.1 per 100,000 for iGAS (range: 2.1–6.7), 5.2 for iGBS (4.0–6.3) and 10.1 for iGCGS (5.4–17.6). The incidence displayed an increasing trend for all groups, albeit for iGBS only for individuals 45 years and older. The increase was particularly sharp for iGCGS (8% annual relative increase). The incidence rate was higher in males for iGCGS (adjusted incidence rate ratio (IRR) = 1.6; 95% confidence interval (CI): 1.5–1.8) and iGAS (adjusted IRR = 1.3; 95% CI: 1.1–1.4); for iGBS, the association with sex was age-dependent. In adults, iGCGS incidence increased significantly with age. Recurrency was seen for iGCGS and secondarily iGBS, but not for iGAS. Infections with iGCGS and iGBS peaked in July and August.

Conclusions

The incidence of invasive beta-haemolytic streptococcal infections in Finland has been rising since 2006, especially for iGCGS and among the elderly population. However, national surveillance still focuses on iGAS and iGBS, and European Union-wide surveillance is lacking. We recommend that surveillance of iGCGS be enhanced, including systematic collection and typing of isolates, to guide infection prevention strategies.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2023.28.31.2200807
2023-08-03
2024-11-21
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2023.28.31.2200807
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/28/31/eurosurv-28-31-3.html?itemId=/content/10.2807/1560-7917.ES.2023.28.31.2200807&mimeType=html&fmt=ahah

References

  1. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685-94.  https://doi.org/10.1016/S1473-3099(05)70267-X  PMID: 16253886 
  2. Ballard MS, Schønheyder HC, Knudsen JD, Lyytikäinen O, Dryden M, Kennedy KJ, et al. The changing epidemiology of group B streptococcus bloodstream infection: a multi-national population-based assessment. Infect Dis (Lond). 2016;48(5):386-91.  https://doi.org/10.3109/23744235.2015.1131330  PMID: 26759190 
  3. Rodriguez-Granger J, Alvargonzalez JC, Berardi A, Berner R, Kunze M, Hufnagel M, et al. Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Eur J Clin Microbiol Infect Dis. 2012;31(9):2097-104.  https://doi.org/10.1007/s10096-012-1559-0  PMID: 22314410 
  4. Sherwood E, Vergnano S, Kakuchi I, Bruce MG, Chaurasia S, David S, et al. Invasive group A streptococcal disease in pregnant women and young children: a systematic review and meta-analysis. Lancet Infect Dis. 2022;22(7):1076-88.  https://doi.org/10.1016/S1473-3099(21)00672-1  PMID: 35390294 
  5. Lancefield RC. A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med. 1933;57(4):571-95.  https://doi.org/10.1084/jem.57.4.571  PMID: 19870148 
  6. Broyles LN, Van Beneden C, Beall B, Facklam R, Shewmaker PL, Malpiedi P, et al. Population-based study of invasive disease due to β-hemolytic streptococci of groups other than A and B. Clin Infect Dis. 2009;48(6):706-12.  https://doi.org/10.1086/597035  PMID: 19187026 
  7. Rantala S. Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection. Eur J Clin Microbiol Infect Dis. 2014;33(8):1303-10.  https://doi.org/10.1007/s10096-014-2092-0  PMID: 24682845 
  8. Turner CE, Bubba L, Efstratiou A. Pathogenicity factors in group C and G streptococci. Microbiol Spectr. 2019;7(3):7.3.4.  https://doi.org/10.1128/microbiolspec.GPP3-0020-2018  PMID: 31111818 
  9. Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E, et al. emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis. 1999;5(2):247-53.  https://doi.org/10.3201/eid0502.990209  PMID: 10221877 
  10. Jensen A, Kilian M. Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes. J Clin Microbiol. 2012;50(1):113-26.  https://doi.org/10.1128/JCM.05900-11  PMID: 22075580 
  11. Smit PW, Lindholm L, Lyytikäinen O, Jalava J, Pätäri-Sampo A, Vuopio J. Epidemiology and emm types of invasive group A streptococcal infections in Finland, 2008-2013. Eur J Clin Microbiol Infect Dis. 2015;34(10):2131-6.  https://doi.org/10.1007/s10096-015-2462-2  PMID: 26292935 
  12. Latronico F, Nasser W, Puhakainen K, Ollgren J, Hyyryläinen HL, Beres SB, et al. Genomic characteristics behind the spread of bacteremic group A Streptococcus Type emm 89 in Finland, 2004-2014. J Infect Dis. 2016;214(12):1987-95.  https://doi.org/10.1093/infdis/jiw468  PMID: 27707808 
  13. Vilhonen J, Vuopio J, Vahlberg T, Gröndahl-Yli-Hannuksela K, Rantakokko-Jalava K, Oksi J. Group A streptococcal bacteremias in Southwest Finland 2007-2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection. Eur J Clin Microbiol Infect Dis. 2020;39(7):1339-48.  https://doi.org/10.1007/s10096-020-03851-6  PMID: 32096108 
  14. Siljander T, Lyytikäinen O, Vähäkuopus S, Snellman M, Jalava J, Vuopio J. Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland. Eur J Clin Microbiol Infect Dis. 2010;29(10):1229-35.  https://doi.org/10.1007/s10096-010-0989-9  PMID: 20563620 
  15. Oppegaard O, Mylvaganam H, Kittang BR. Beta-haemolytic group A, C and G streptococcal infections in Western Norway: a 15-year retrospective survey. Clin Microbiol Infect. 2015;21(2):171-8.  https://doi.org/10.1016/j.cmi.2014.08.019  PMID: 25658557 
  16. Kittang BR, Bruun T, Langeland N, Mylvaganam H, Glambek M, Skrede S. Invasive group A, C and G streptococcal disease in western Norway: virulence gene profiles, clinical features and outcomes. Clin Microbiol Infect. 2011;17(3):358-64.  https://doi.org/10.1111/j.1469-0691.2010.03253.x  PMID: 20456456 
  17. Laupland KB, Pasquill K, Parfitt EC, Steele L. Bloodstream infection due to β-hemolytic streptococci: a population-based comparative analysis. Infection. 2019;47(6):1021-5.  https://doi.org/10.1007/s15010-019-01356-9  PMID: 31515703 
  18. Lambertsen LM, Ingels H, Schønheyder HC, Hoffmann S, Danish Streptococcal Surveillance Collaboration Group 2011. Nationwide laboratory-based surveillance of invasive beta-haemolytic streptococci in Denmark from 2005 to 2011. Clin Microbiol Infect. 2014;20(4):O216-23.  https://doi.org/10.1111/1469-0691.12378  PMID: 24125634 
  19. Gajdács M, Ábrók M, Lázár A, Burián K. Beta-haemolytic group A, C and G streptococcal infections in southern Hungary: a 10-year population-based retrospective survey (2008-2017) and a review of the literature. Infect Drug Resist. 2020;13:4739-49.  https://doi.org/10.2147/IDR.S279157  PMID: 33408489 
  20. Lyytikäinen O, Nuorti JP, Halmesmäki E, Carlson P, Uotila J, Vuento R, et al. Invasive group B streptococcal infections in Finland: a population-based study. Emerg Infect Dis. 2003;9(4):469-73.  https://doi.org/10.3201/eid0904.020481  PMID: 12702228 
  21. Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjänen J. Clinical presentations and epidemiology of β-haemolytic streptococcal bacteraemia: a population-based study. Clin Microbiol Infect. 2009;15(3):286-8.  https://doi.org/10.1111/j.1469-0691.2008.02672.x  PMID: 19175622 
  22. Schwartz IS, Keynan Y, Gilmour MW, Dufault B, Lagacé-Wiens P. Changing trends in β-hemolytic streptococcal bacteremia in Manitoba, Canada: 2007-2012. Int J Infect Dis. 2014;28:211-3.  https://doi.org/10.1016/j.ijid.2014.03.1376  PMID: 25403914 
  23. Sylvetsky N, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients. Am J Med. 2002;112(8):622-6.  https://doi.org/10.1016/S0002-9343(02)01117-8  PMID: 12034411 
  24. United Kingdom Health Security Agency (UKHSA). Laboratory surveillance of pyogenic and non-pyogenic streptococcal bacteraemia in England: 2020 update. Health Protection Report. 2020;15(19). Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1036011/hpr1921_strptcccl-BSI_2020.pdf
  25. Harris P, Siew DA, Proud M, Buettner P, Norton R. Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period. Clin Microbiol Infect. 2011;17(8):1216-22.  https://doi.org/10.1111/j.1469-0691.2010.03427.x  PMID: 21073630 
  26. Ekelund K, Skinhøj P, Madsen J, Konradsen HB. Invasive group A, B, C and G streptococcal infections in Denmark 1999-2002: epidemiological and clinical aspects. Clin Microbiol Infect. 2005;11(7):569-76.  https://doi.org/10.1111/j.1469-0691.2005.01169.x  PMID: 15966976 
  27. Kontula KSK, Skogberg K, Ollgren J, Järvinen A, Lyytikäinen O. Population-based study of bloodstream infection incidence and mortality rates, Finland, 2004-2018. Emerg Infect Dis. 2021;27(10):2560-9.  https://doi.org/10.3201/eid2710.204826  PMID: 34546161 
  28. Slotved HC, Hoffmann S. The epidemiology of invasive group B Streptococcus in Denmark from 2005 to 2018. Front Public Health. 2020;8:40.  https://doi.org/10.3389/fpubh.2020.00040  PMID: 32211361 
  29. Loubinoux J, Plainvert C, Collobert G, Touak G, Bouvet A, Poyart C, et al. Adult invasive and noninvasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France from 2006 to 2010. J Clin Microbiol. 2013;51(8):2724-7.  https://doi.org/10.1128/JCM.01262-13  PMID: 23698531 
  30. Pinho MD, Melo-Cristino J, Ramirez M. Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness. J Clin Microbiol. 2006;44(3):841-6.  https://doi.org/10.1128/JCM.44.3.841-846.2006  PMID: 16517864 
  31. Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol. 2009;47(4):1155-65.  https://doi.org/10.1128/JCM.02155-08  PMID: 19158266 
  32. Efstratiou A, Lamagni T. Epidemiology of Streptococcus pyogenes. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations. Oklahoma City: University of Oklahoma Health Sciences Center; 2016.  PMID: 26866237 
  33. Laupland KB, Pasquill K, Parfitt EC, Steele L. Bloodstream infection due to β-hemolytic streptococci: a population-based comparative analysis. Infection. 2019;47(6):1021-5.  https://doi.org/10.1007/s15010-019-01356-9  PMID: 31515703 
  34. Park JH, Jung J, Kim MJ, Sung H, Kim MN, Chong YP, et al. Incidence, clinical characteristics, and outcomes of Streptococcus dysgalactiae subspecies equisimilis bacteremia in a tertiary hospital: comparison with S. agalactiae bacteremia. Eur J Clin Microbiol Infect Dis. 2019;38(12):2253-8.  https://doi.org/10.1007/s10096-019-03667-z  PMID: 31392445 
  35. Rantala S, Vähäkuopus S, Vuopio-Varkila J, Vuento R, Syrjänen J. Streptococcus dysgalactiae subsp. equisimilis Bacteremia, Finland, 1995-2004. Emerg Infect Dis. 2010;16(5):843-6.  https://doi.org/10.3201/eid1605.080803  PMID: 20409380 
  36. Liao CH, Liu LC, Huang YT, Teng LJ, Hsueh PR. Bacteremia caused by group G Streptococci, Taiwan. Emerg Infect Dis. 2008;14(5):837-40.  https://doi.org/10.3201/eid1405.070130  PMID: 18439377 
  37. Creti R. Have group A and B streptococcal infections become neglected diseases in Europe? Eur J Clin Microbiol Infect Dis. 2017;36(7):1063-4.  https://doi.org/10.1007/s10096-017-2984-x  PMID: 28432474 
Invasive beta-haemolytic streptococcal infections, Finland, 2006 to 2020: increase in Lancefield group C/G infections
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Dafni+Katerina+Paspaliari&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Paspaliari Dafni Katerina</a>, <a href="/search?value1=Emmi+Sarvikivi&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Sarvikivi Emmi</a>, <a href="/search?value1=Jukka+Ollgren&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ollgren Jukka</a>, <a href="/search?value1=Jaana+Vuopio&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vuopio Jaana</a></span>. Invasive beta-haemolytic streptococcal infections, Finland, 2006 to 2020: increase in Lancefield group C/G infections. <a href="/content/ecdc">Euro Surveill.</a> 2023;28(31):pii=2200807. <a href="https://doi.org/10.2807/1560-7917.ES.2023.28.31.2200807" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2023.28.31.2200807</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 03 Oct 2022;&nbsp;&nbsp; <span class="generated">Accepted</span>: 13 Mar 2023 </span> </p>
/content/10.2807/1560-7917.ES.2023.28.31.2200807
/content/10.2807/1560-7917.ES.2023.28.31.2200807
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error